# Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent

> **NCT02118870** · PHASE4 · COMPLETED · sponsor: **Diagram B.V.** · enrollment: 1500 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Treatment 90 days DAPT
- **DRUG:** Treatment 360 days DAPT

## Key facts

- **NCT ID:** NCT02118870
- **Lead sponsor:** Diagram B.V.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-10
- **Primary completion:** 2017-09
- **Final completion:** 2018-09
- **Target enrollment:** 1500 (ACTUAL)
- **Last updated:** 2019-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02118870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02118870, "Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02118870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*